|
V93572
|
(2R)-Naroparcil
|
252647-51-1 |
(2R)-Naroparcil is an isomer of Naroparcil, a 4-methylumbelliferyl β-D-xyloside analog that promotes vascular smooth muscle cell proliferation and has been shown to inhibit Weissler thrombosis in the slough model. |
|
V96934
|
(2R,3R)-GSK973
|
|
(2R,3R)-GSK973 is an isomer of GSK973. |
|
V93576
|
(2R,3S)-Azelaprag
|
2049979-31-7 |
(2R,3S)-Azelaprag ((2R,3S)-AMG 986) is an Apelin receptor agonist with an EC50 of 0.012 µM for Apelin receptor, used to inhibit various diseases such as heart failure, atherosclerosis, obesity, diabetes, amyotrophic lateral sclerosis, coronary artery disease, hypertension, stroke and myocardial infarction. |
|
V100841
|
(2S)-3-Keto sphinganine (d8:0) (hydrochloride)
|
1314998-90-7 |
(2S)-3-Ketosphingosine (d8:0) (hydrochloride) ((2S)-3-Keto-c8-dihydrosphingosine (hydrochloride)) is an ester product. |
|
V100917
|
(2S,3R,E)-2-Aminohexadec-4-ene-1,3-diol
|
6982-09-8 |
(2S,3R,E)-2-Aminohexadec-4-ene-1,3-diol is an ester product. |
|
V100309
|
(2S,3R,E)-2-Aminopentadec-4-ene-1,3-diol
|
86555-28-4 |
(2S,3R,E)-2-Aminopentadeca-4-ene-1,3-diol is an ester product. |
|
V93672
|
(2Z,3Z)-U0126
|
218601-62-8 |
(2Z,3Z)-U0126 is a selective inhibitor of MEK1 and MEK2, exhibiting potent anti-inflammatory effects through non-competitive inhibition of AP-1 transcriptional activity with IC50 values of 72 nM for MEK1 and 58 nM for MEK2. |
|
V94146
|
(3aR,9aR)-Fluparoxan
|
105182-47-6 |
(3aR,9aR)-Fluparoxan ((3aR,9aR)-GR50360) is a highly selective and potent α2B adrenergic receptor antagonist with activity in preventing, ameliorating or inhibiting neurodevelopmental disorders and neurodegenerative diseases. |
|
V93664
|
(3S,5R)-Fluvastatin potassium
|
1009811-63-5 |
(3S,5R)-Fluvastatin (potassium) is a synthetic hypolipidemic drug that inhibits HMG-CoA reductase activity. |
|
V93434
|
(4-?(Bromomethyl)?phenyl)?(4-?(prop-?2-?yn-?1-?yloxy)?phenyl)?methanone
|
1695554-80-3 |
(4-(Bromomethyl)phenyl)-(4-(prop-2-yn-1-yloxy)phenyl)methanone is a compound with anticancer activity, which can effectively inhibit the growth of tumor cells and has potential application value in compound development. |
|
V93323
|
(4-Aminobenzyl)phosphonic acid
|
5424-27-1 |
(4-Aminobenzyl)phosphonic acid is a bioactive compound with potential anticancer and antibacterial activities. |
|
V94460
|
(5aS,6R,6aR)-MK-8666
|
1544739-76-5 |
(5aS,6R,6aR)-MK-8666 is a selective GPR40 agonist with activity in promoting fatty acid-induced insulin secretion in pancreatic β-cells and intestinal enteroendocrine cells. |
|
V100863
|
(7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaen-4-ynoic acid
|
660429-97-0 |
(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaen-4-ynoic acid is an ester product. |
|
V100905
|
(8(Z),11Z)-Methyl 13-(3-pentyloxiran-2-yl)trideca-8,11-dienoate
|
2692622-73-2 |
Methyl (8(Z),11Z)-13-(3-pentyloxirane-2-yl)trideca-8,11-dienoate (Methyl (8Z,11Z)-13-((2S,3R)-3-pentyloxirane-2-yl)trideca-8,11-dienoate) is an ester product. |
|
V100312
|
(9E,11E)-9-Nitro-9,11-octadecadienoic acid
|
1417651-32-1 |
(9E,11E)-9-Nitro-9,11-octadecadienoic acid (9E,11E-9-nitroCLA) is a nitrated fatty acid formed by exposure of 9Z,11E-CLA to acidified nitrite, peroxynitrite, gaseous nitrogen dioxide, or a combination of myeloperoxidase, hydrogen peroxide, and nitrite. |
|
V100341
|
(9Z,12Z)-15-Hydroxyoctadeca-9,12-dienoic acid
|
177931-23-6 |
(9Z,12Z)-15-Hydroxyoctadec-9,12-dienoic acid (15(R)-Hydroxy-9(Z),12(Z)-octadecadienoic acid) is an ester product. |
|
V93494
|
(CAAC-Cy)Rh(COD)Cl
|
1801869-83-9 |
(CAAC-Cy)Rh(COD)Cl is a rhodium-based catalyst with remarkable hydrogenation activity. |
|
V98043
|
(DHQD)2PHAL
|
140853-10-7 |
(DHQD)2PHAL is a dimer that can be used as a ligand for the Sharpless asymmetric dihydroxylation reaction. |
|
V94742
|
(E)-2-Hexadecenal alkyne
|
1778692-99-1 |
(E)-2-Hexadecenal alkyne (compound 2) is a chemical probe used to explore the cellular targets of 2-trans-hexadecenal. It can covalently modify multiple proteins in cells and provide a tool for studying lipid metabolism-related diseases. |
|
V98106
|
(E)-4-Hydroxycrotonic acid
|
24587-49-3 |
(E)-4-Hydroxycrotonic acid (T-HCA) is a high-affinity GHB binding site ligand with a ki value of 1.1 μM. |